Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin.
about
Complexity of immune responses to AAV transgene products - Example of factor IX.Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice.Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A.Combination Therapy Is the New Gene Therapy?
P2860
Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Combination therapy for inhibi ...... lonal anti-CD20 and rapamycin.
@en
Combination therapy for inhibi ...... lonal anti-CD20 and rapamycin.
@nl
type
label
Combination therapy for inhibi ...... lonal anti-CD20 and rapamycin.
@en
Combination therapy for inhibi ...... lonal anti-CD20 and rapamycin.
@nl
prefLabel
Combination therapy for inhibi ...... lonal anti-CD20 and rapamycin.
@en
Combination therapy for inhibi ...... lonal anti-CD20 and rapamycin.
@nl
P2093
P2860
P356
P1476
Combination therapy for inhibi ...... clonal anti-CD20 and rapamycin
@en
P2093
Alexandra Sherman
Barry J Byrne
David M Markusic
Geoffrey L Rogers
Haiyan Jiang
Roland W Herzog
P2860
P356
10.1160/TH16-05-0404
P577
2016-09-29T00:00:00Z